Apelin (APLN) has been hypothesized to be associated with MASLD progression and the gut microbiota, particularly associated with the abundance of Enterobactericae, Prevotellaceae, and Lactobacillaceae. This evidence concerns the gene APLN and metabolic dysfunction-associated steatotic liver disease.